GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » Intrinsic Value: Projected FCF

Biosino Bio-Technology and Science (HKSE:08247) Intrinsic Value: Projected FCF : HK$-0.40 (As of Jun. 10, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Biosino Bio-Technology and Science Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-10), Biosino Bio-Technology and Science's Intrinsic Value: Projected FCF is HK$-0.40. The stock price of Biosino Bio-Technology and Science is HK$0.70. Therefore, Biosino Bio-Technology and Science's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Biosino Bio-Technology and Science's Intrinsic Value: Projected FCF or its related term are showing as below:

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Biosino Bio-Technology and Science was 1.36. The lowest was 0.97. And the median was 1.19.

HKSE:08247's Price-to-Projected-FCF is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.62
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Biosino Bio-Technology and Science Intrinsic Value: Projected FCF Historical Data

The historical data trend for Biosino Bio-Technology and Science's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosino Bio-Technology and Science Intrinsic Value: Projected FCF Chart

Biosino Bio-Technology and Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.95 -0.89 -0.31 -0.15 -0.40

Biosino Bio-Technology and Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.15 - - - -0.40

Competitive Comparison of Biosino Bio-Technology and Science's Intrinsic Value: Projected FCF

For the Diagnostics & Research subindustry, Biosino Bio-Technology and Science's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosino Bio-Technology and Science's Price-to-Projected-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biosino Bio-Technology and Science's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Biosino Bio-Technology and Science's Price-to-Projected-FCF falls into.



Biosino Bio-Technology and Science Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Biosino Bio-Technology and Science's Free Cash Flow(6 year avg) = HK$-25.36.

Biosino Bio-Technology and Science's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec23)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-25.358142857143+230.117*0.8)/144.707
=-0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosino Bio-Technology and Science  (HKSE:08247) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Biosino Bio-Technology and Science's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.70/-0.3961441797612
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosino Bio-Technology and Science Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Biosino Bio-Technology and Science's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosino Bio-Technology and Science (HKSE:08247) Business Description

Traded in Other Exchanges
N/A
Address
No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of in-vitro diagnostic (IVD) reagent products. the company's revenue is generated from customers located in Mainland China.
Executives
Beijing Enterprises Group Company Limited 2201 Interest of corporation controlled by you
Beijing Enterprises Holdings Limited 2101 Beneficial owner
Hk Zhixin Investment Co., Ltd. 2101 Beneficial owner
Li Dongfeng 2201 Interest of corporation controlled by you
Yan Kang 2201 Interest of corporation controlled by you
Qiu Zhe Feng 2201 Interest of corporation controlled by you
Hai Nan Zhi Xin Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Yun Nan Sheng Neng Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Li Yang Yi Xiong 2201 Interest of corporation controlled by you

Biosino Bio-Technology and Science (HKSE:08247) Headlines

No Headlines